Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: What does heritability of Alzheimer’s disease represent?

  • Emily Baker,
  • Ganna Leonenko,
  • Karl Michael Schmidt,
  • Matthew Hill,
  • Amanda J. Myers,
  • Maryam Shoai,
  • Itziar de Rojas,
  • Niccoló Tesi,
  • Henne Holstege,
  • Wiesje M. van der Flier,
  • Yolande A. L. Pijnenburg,
  • Agustin Ruiz,
  • John Hardy,
  • Sven van der Lee,
  • Valentina Escott-Price

The following information is missing from the Acknowledgements section: The results published here are in whole or in part based on data obtained from the AD Knowledge Portal (https://adknowledgeportal.org). ROSMAP data were provided by the Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago. Data collection was supported through funding by NIA grants P30AG10161 (ROS), R01AG15819 (ROSMAP; genomics and RNAseq), R01AG17917 (MAP), R01AG30146, R01AG36042 (5hC methylation, ATACseq), RC2AG036547 (H3K9Ac), R01AG36836 (RNAseq), R01AG48015 (monocyte RNAseq) RF1AG57473 (single nucleus RNAseq), U01AG32984 (genomic and whole exome sequencing), U01AG46152 (ROSMAP AMP-AD, targeted proteomics), U01AG46161(TMT proteomics), U01AG61356 (whole genome sequencing, targeted proteomics, ROSMAP AMP-AD), the Illinois Department of Public Health (ROSMAP), and the Translational Genomics Research Institute (genomic). Additional phenotypic data can be requested at www.radc.rush.edu. MSBB data were generated from postmortem brain tissue collected through the Mount Sinai VA Medical Center Brain Bank and were provided by Dr. Eric Schadt from Mount Sinai School of Medicine. The Mayo RNAseq study data was led by Dr. Nilüfer Ertekin-Taner, Mayo Clinic, Jacksonville, Florida as part of the multi-PI U01 AG046139 (MPIs Golde, Ertekin-Taner, Younkin, Price). Samples were provided from the following sources: The Mayo Clinic Brain Bank. Data collection was supported through funding by NIA grants P50 AG016574, R01 AG032990, U01 AG046139, R01 AG018023, U01 AG006576, U01 AG006786, R01 AG025711, R01 AG017216, R01 AG003949, NINDS grant R01 NS080820, CurePSP Foundation, and support from Mayo Foundation. Study data includes samples collected through the Sun Health Research Institute Brain and Body Donation Program of Sun City, Arizona. The Brain and Body Donation Program is supported by the National Institute of Neurological Disorders and Stroke (U24 NS072026 National Brain and Tissue Resource for Parkinsons Disease and Related Disorders), the National Institute on Aging (P30 AG19610 Arizona Alzheimers Disease Core Center), the Arizona Department of Health Services (contract, Arizona Alzheimers Research Center), the Arizona Biomedical Research Commission (contracts, 05-901 and to the Arizona Parkinson’s Disease Consortium) and the Michael J. Fox Foundation for Parkinsons Research.

Reference

  1. 1. Baker E, Leonenko G, Schmidt KM, Hill M, Myers AJ, Shoai M, et al. What does heritability of Alzheimer’s disease represent?. PLoS One. 2023;18(4):e0281440. pmid:37115753

Citation: Baker E, Leonenko G, Schmidt KM, Hill M, Myers AJ, Shoai M, et al. (2025) Correction: What does heritability of Alzheimer’s disease represent? PLoS One 20(5): e0323769. https://doi.org/10.1371/journal.pone.0323769

Published: May 12, 2025

Copyright: © 2025 Baker et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.